Literature DB >> 7676610

Enumeration of isotype-specific antibody-secreting cells derived from gnotobiotic piglets inoculated with porcine rotaviruses.

W K Chen1, T Campbell, J VanCott, L J Saif.   

Abstract

In order to evaluate mucosal antibody responses to rotavirus, an enzyme-linked immunospot (ELISPOT) assay was adapted to enumerate antibody-secreting cells (ASC) in the mesenteric lymph nodes (MLN), lamina propria (LP) of the small intestine and spleens of gnotobiotic pigs orally inoculated with porcine rotaviruses (SB1A and Gottfried). Rotavirus-specific IgM ASC occurred by post-inoculation day (PID) 3, and numbers peaked in spleen and MLN tissues by PID 7 and in intestinal LP by PID 7-14. Numbers of rotavirus specific IgA and IgG ASC in these tissues peaked at PID 14-21. Rotavirus specific IgA ASC were predominant in the gut and IgA to IgG rotavirus specific ASC ratios were highest for all rotavirus antigen coatings in the gut LP. However, the relative ratios of specific IgA to IgG ASC were lower (ratios of 5 to 7) against combined structural and nonstructural viral antigens (rotavirus-infected fixed cell ELISPOT plates) than ratios (13 to 46) against only viral structural antigens (rotavirus-coated ELISPOT plates), indicating that there were proportionately more specific IgG ASC to the nonstructural viral antigens in the LP, the tissue adjacent to the site of rotavirus replication in the intestine. In the node cells (spleen and MLN) rotavirus-specific IgA to IgG ASC ratios were lowest and against the various ELISPOT rotavirus coatings ranged from 0.7 to 4. Gnotobiotic piglets inoculated at different ages with porcine rotaviruses generally showed similar specific immunoglobulin (Ig) ASC responses to rotavirus infection, along with similar diarrhea and virus shedding patterns in the different age groups. However, the numbers of specific IgA ASC in the MLN of 3-4 week old pigs were higher than those of 3-5 day old pigs. Although challenge of SB1A or Gottfried rotavirus-inoculated pigs with SB1A (G4P7) or Gottfried (G4P6) rotavirus revealed a high degree of protection from diarrhea and virus shedding, greater numbers of specific IgM ASC were observed in spleen after challenge of SB1A-inoculated pigs with Gottfried rotavirus (same G type, distinct P type). Thus, by using the ELISPOT technique, we successfully measured intestinal mucosal antibody-related responses to rotavirus in gnotobiotic pigs. Moreover, our results support the use of gnotobiotic piglets as an animal model to evaluate active antibody responses and protection against rotavirus infection and disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676610      PMCID: PMC7119826          DOI: 10.1016/0165-2427(94)05343-q

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  41 in total

Review 1.  The mucosal immune system: from fundamental concepts to vaccine development.

Authors:  J R McGhee; J Mestecky; M T Dertzbaugh; J H Eldridge; M Hirasawa; H Kiyono
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies.

Authors:  P A Offit; H F Clark
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

3.  Preponderance of IgM from blood lymphocytes in response to infantile rotavirus gastroenteritis.

Authors:  M Kaila; E Isolauri; E Virtanen; H Arvilommi
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

4.  VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection.

Authors:  R D Shaw; W S Groene; E R Mackow; A A Merchant; E H Cheng
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection.

Authors:  P A Offit; K I Dudzik
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

6.  Murine intestinal antibody response to heterologous rotavirus infection.

Authors:  A A Merchant; W S Groene; E H Cheng; R D Shaw
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

7.  Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge.

Authors:  J L VanCott; T A Brim; J K Lunney; L J Saif
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

8.  Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus.

Authors:  M K Ijaz; S K Attah-Poku; M J Redmond; M D Parker; M I Sabara; P Frenchick; L A Babiuk
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Responses of intraepithelial lymphocytes to T-cell mitogens: a comparison between murine and porcine responses.

Authors:  A D Wilson; C R Stokes; F J Bourne
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

10.  Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children.

Authors:  K Grimwood; J C Lund; B S Coulson; I L Hudson; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

View more
  13 in total

1.  Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.

Authors:  L Yuan; L A Ward; B I Rosen; T L To; L J Saif
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

2.  Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus.

Authors:  L Yuan; S Y Kang; L A Ward; T L To; L J Saif
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

3.  Effects of maternal antibodies on protection and development of antibody responses to human rotavirus in gnotobiotic pigs.

Authors:  D C Hodgins; S Y Kang; L deArriba; V Parreño; L A Ward; L Yuan; T To; L J Saif
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain).

Authors:  M Souza; S M Cheetham; M S P Azevedo; V Costantini; L J Saif
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

5.  Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus.

Authors:  M Souza; M S P Azevedo; K Jung; S Cheetham; L J Saif
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

6.  Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.

Authors:  L Yuan; C Iosef; M S Azevedo; Y Kim; Y Qian; A Geyer; T V Nguyen; K O Chang; L J Saif
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.

Authors:  L Yuan; A Geyer; D C Hodgins; Z Fan; Y Qian; K O Chang; S E Crawford; V Parreño; L A Ward; M K Estes; M E Conner; L J Saif
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Relative importance of rotavirus-specific effector and memory B cells in protection against challenge.

Authors:  C A Moser; S Cookinham; S E Coffin; H F Clark; P A Offit
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  Short-term immunoglobulin A B-cell memory resides in intestinal lymphoid tissues but not in bone marrow of gnotobiotic pigs inoculated with Wa human rotavirus.

Authors:  L Yuan; A Geyer; L J Saif
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

10.  A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.

Authors:  Menira Souza; Veronica Costantini; Marli S P Azevedo; Linda J Saif
Journal:  Vaccine       Date:  2007-10-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.